The synthetic cannabinoid WIN55,212-2 mesylate decreases the production of inflammatory mediators in rheumatoid arthritis synovial fibroblasts by activating CB2, TRPV1, TRPA1 and yet unidentified receptor targets

被引:0
|
作者
Torsten Lowin
Georg Pongratz
Rainer H. Straub
机构
[1] University Hospital Duesseldorf,Funktionsbereich & Hiller Forschungszentrum für Rheumatologie, Life Science Center
[2] University Hospital of Regensburg,Laboratory of Experimental Rheumatology and Neuroendocrine Immunology
来源
Journal of Inflammation | / 13卷
关键词
Cannabinoid; Synovial fibroblasts; Cytokines; MMP; Proliferation; Arthritis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 4 条
  • [1] The synthetic cannabinoid WIN55,212-2 mesylate decreases the production of inflammatory mediators in rheumatoid arthritis synovial fibroblasts by activating CB2, TRPV1, TRPA1 and yet unidentified receptor targets
    Lowin, Torsten
    Pongratz, Georg
    Straub, Rainer H.
    JOURNAL OF INFLAMMATION-LONDON, 2016, 13
  • [2] Synthetic cannabinoid WIN55,212-2 inhibits generation of inflammatory mediators by IL-1β-stimulated human astrocytes
    Sheng, WS
    Hu, SX
    Min, XN
    Cabral, GA
    Lokensgard, JR
    Peterson, PK
    GLIA, 2005, 49 (02) : 211 - 219
  • [3] Anti-inflammatory effects of N-acylethanolamines in rheumatoid arthritis synovial cells are mediated by TRPV1 and TRPA1 in a COX-2 dependent manner
    Torsten Lowin
    Martin Apitz
    Sven Anders
    Rainer H. Straub
    Arthritis Research & Therapy, 17
  • [4] Anti-inflammatory effects of N-acylethanolamines in rheumatoid arthritis synovial cells are mediated by TRPV1 and TRPA1 in a COX-2 dependent manner
    Lowin, Torsten
    Apitz, Martin
    Anders, Sven
    Straub, Rainer H.
    ARTHRITIS RESEARCH & THERAPY, 2015, 17